Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Verzistobart by Incyte for Merkel Cell Carcinoma: Likelihood of Approval
Verzistobart is under clinical development by Incyte and currently in Phase II for Merkel Cell Carcinoma. According to GlobalData, Phase...